Howard M. Lazarus's most recent trade in Avalyn Pharma Inc. was a trade of 211,975 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avalyn Pharma Inc | Howard M. Lazarus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2026 | 211,975 | 211,975 | - | - | Stock Option (Right to Buy) |